Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

FDA Gives Nod To BioSante's Estrogen Drug In Hot Flashes

Dec. 19, 2006

By Aaron Lorenzo

FDA Weighing Expanded Use, Sales Of Experimental Drugs

Dec. 18, 2006

By Aaron Lorenzo

Affymax Completes $92M IPO; Funds Planned For EPO Drug

Dec. 18, 2006

By Aaron Lorenzo

FDA Weighing Expanded Use, Sales Of Experimental Drugs

Dec. 18, 2006

By Aaron Lorenzo

Affymax Completes $92M IPO; Funds Planned For EPO Drug

Dec. 18, 2006

By Aaron Lorenzo

GTx Raises $61M To Progress Late-Stage Drug Development

Dec. 15, 2006

By Aaron Lorenzo

GTx Raises $61M To Progress Late-Stage Drug Development

Dec. 15, 2006

By Aaron Lorenzo

Pain's Oxytrex Study Recruiting Highly Dependent Opioid Users

Dec. 14, 2006

By Aaron Lorenzo

Pain's Oxytrex Study Recruiting Highly Dependent Opioid Users

Dec. 14, 2006

By Aaron Lorenzo

Indevus To Pay $120M For Valera In Specialty Buyout

Dec. 13, 2006

By Aaron Lorenzo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 23, 2025
Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal
BioWorld
The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...
Proteomics study explores how protein changes influence disease
BioWorld Science
Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...
Abbvie and Simcere enter a $1B T-cell engager deal
BioWorld Asia
Abbvie Inc. and Simcere Zaiming Pharmaceutical Co. Ltd. are part of the volley of large deals accompanying the opening of the 43rd annual J.P. Morgan Healthcare...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.